April 9, 2019 / 9:16 AM / 6 months ago

REFILE-BRIEF-Shanghai Fosun Pharmaceutical's Units Plan Project, Sign Licence Agreement With UK Firm

(Adds bullet point, link)

April 9 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd:

* SAYS UNIT PLANS BIO-PHARMA PROJECT WITH INVESTMENT OF UP TO 1.0 BILLION YUAN ($149.09 million)

* SAYS BOARD APPROVES UNIT TO SIGN LICENSE AGREEMENT WITH RENEURON LIMITED IN U.K. Source text in Chinese: bit.ly/2VFk3Fq; bit.ly/2I5UgmV Further company coverage: ($1 = 6.7075 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below